Strs Ohio Purchases New Position in National HealthCare Corporation $NHC

Key Points

• Strs Ohio bought a new position of 5,900 shares (~$809,000) in National HealthCare (NHC) in Q4; institutional ownership is about 56.44% and several other funds also initiated or increased stakes.
• NHC reported quarterly EPS of $1.91 on $381.82 million in revenue, and the stock trades near $171.42 with a market cap of $2.67 billion and a P/E of 22.35.
• The company pays a quarterly dividend of $0.64 (annualized $2.56), implying a yield of ~1.5% and a payout ratio of 59.12%.

Strs Ohio purchased a new stake in National HealthCare Corporation (NYSEAMERICAN:NHC - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 5,900 shares of the company's stock, valued at approximately $809,000.

Several other large investors have also made changes to their positions in NHC. Caitong International Asset Management Co. Ltd bought a new stake in shares of National HealthCare in the 3rd quarter valued at approximately $25,000. Quarry LP grew its stake in shares of National HealthCare by 171.9% in the 3rd quarter. Quarry LP now owns 261 shares of the company's stock valued at $32,000 after buying an additional 165 shares in the last quarter. Raymond James Financial Inc. bought a new stake in shares of National HealthCare in the 2nd quarter valued at approximately $58,000. EverSource Wealth Advisors LLC boosted its position in National HealthCare by 219.7% during the second quarter. EverSource Wealth Advisors LLC now owns 633 shares of the company's stock worth $68,000 after purchasing an additional 435 shares during the period. Finally, Exchange Traded Concepts LLC bought a new stake in National HealthCare during the fourth quarter worth approximately $71,000. Institutional investors own 56.44% of the company's stock.

National HealthCare Stock Up 1.2%

Shares of National HealthCare stock opened at $171.42 on Friday. The stock has a market capitalization of $2.67 billion, a P/E ratio of 22.35 and a beta of 0.64. The stock has a 50 day moving average price of $165.30 and a two-hundred day moving average price of $147.81. National HealthCare Corporation has a 12-month low of $93.54 and a 12-month high of $184.08.

National HealthCare (NYSEAMERICAN:NHC - Get Free Report) last announced its earnings results on Thursday, May 7th. The company reported $1.91 earnings per share (EPS) for the quarter. The firm had revenue of $381.82 million during the quarter. National HealthCare had a return on equity of 9.59% and a net margin of 7.91%.

National HealthCare Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st were given a dividend of $0.64 per share. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $2.56 dividend on an annualized basis and a yield of 1.5%. National HealthCare's dividend payout ratio is presently 59.12%.

About National HealthCare

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.

Want to see what other hedge funds are holding NHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National HealthCare Corporation (NYSEAMERICAN:NHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.